Masmudur M Rahman Selected Research

Tyrosine Kinase Inhibitors

6/2010

Myxoma and vaccinia viruses exploit different mechanisms to enter and infect human cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masmudur M Rahman Research Topics

Disease

30	Neoplasms (Cancer) 11/2023 - 09/2009
15	Infections 02/2024 - 10/2009
6	Virus Diseases (Viral Diseases) 01/2021 - 10/2009
5	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 04/2010
4	Vaccinia 01/2013 - 05/2007
3	Smallpox (Variola) 01/2021 - 06/2009
3	Ovarian Neoplasms (Ovarian Cancer) 12/2020 - 05/2012
3	Glioma (Gliomas) 01/2016 - 01/2010
2	Multiple Myeloma 01/2022 - 09/2020
2	Residual Neoplasm 09/2020 - 03/2017
1	Disease Progression 12/2022
1	Reinfection 08/2022
1	Adenocarcinoma 04/2022
1	Neoplasm Metastasis (Metastasis) 09/2021
1	Osteosarcoma (Osteogenic Sarcoma) 09/2021
1	Rupture 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Melanoma (Melanoma, Malignant) 09/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019
1	Neuroendocrine Carcinoma 01/2019
1	Embryonal Rhabdomyosarcoma 12/2018
1	Hematologic Diseases (Blood Diseases) 03/2016
1	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2016
1	Lymphoma (Lymphomas) 07/2015
1	Uveitis 01/2015
1	Inflammation (Inflammations) 01/2015
1	Brain Neoplasms (Brain Tumor) 07/2013
1	Glioblastoma (Glioblastoma Multiforme) 07/2013
1	Ascites 05/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2012
1	Autoimmune Diseases (Autoimmune Disease) 08/2011
1	Necrosis 09/2009

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2007
7	Antiviral Agents (Antivirals)IBA 02/2023 - 09/2009
6	CytokinesIBA 12/2022 - 09/2009
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2021 - 08/2011
3	RNA Helicases (RNA Helicase)IBA 01/2023 - 11/2017
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
3	Sirolimus (Rapamycin)FDA Link 07/2013 - 01/2010
2	PHluorinIBA 02/2024 - 08/2023
2	selinexorIBA 02/2023 - 01/2023
2	Viral ProteinsIBA 01/2023 - 09/2009
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 12/2022 - 08/2012
2	Neoplasm Antigens (Tumor Antigens)IBA 12/2022 - 09/2013
2	InterferonsIBA 12/2022 - 09/2009
2	Gemcitabine FDA Link 04/2022 - 04/2012
2	VaccinesIBA 01/2021 - 10/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2007
2	Protein Kinases (Protein Kinase)IBA 01/2021 - 04/2016
2	AntigensIBA 01/2020 - 03/2016
2	Small Interfering RNA (siRNA)IBA 11/2017 - 12/2011
2	Temozolomide (Temodar)FDA LinkGeneric 01/2016 - 07/2013
2	Interleukin-6 (Interleukin 6)IBA 09/2014 - 12/2011
2	InflammasomesIBA 12/2011 - 10/2009
2	ChemokinesIBA 12/2011 - 10/2009
1	KinesinsIBA 02/2024
1	Exportin 1 ProteinIBA 01/2023
1	Chimeric Antigen ReceptorsIBA 12/2022
1	Praziquantel (Biltricide)FDA Link 08/2022
1	Bortezomib (Velcade)FDA Link 01/2022
1	LCL161IBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Therapeutic UsesIBA 01/2022
1	LuciferasesIBA 03/2021
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 12/2020
1	InterleukinsIBA 09/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2018
1	DEAD-box RNA HelicasesIBA 11/2017
1	Protein SIBA 01/2017
1	EndotoxinsIBA 01/2015
1	Green Fluorescent ProteinsIBA 01/2015
1	SuspensionsIBA 05/2012
1	resazurinIBA 05/2012
1	Mitogen-Activated Protein KinasesIBA 12/2011
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2011
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2011
1	Virulence Factors (Pathogenicity Factors)IBA 10/2011
1	Z-Form DNA (Z-DNA)IBA 10/2011
1	Transcription Factors (Transcription Factor)IBA 01/2011
1	Tyrosine Kinase InhibitorsIBA 06/2010
1	GenisteinIBA 06/2010
1	NF-KappaB Inhibitor alphaIBA 10/2009
1	interleukin-1beta-converting enzyme inhibitorIBA 10/2009
1	NF-kappa B (NF-kB)IBA 10/2009
1	Viral DNAIBA 05/2007

Therapy/Procedure

16	Therapeutics 02/2023 - 04/2010
11	Oncolytic Virotherapy 11/2023 - 01/2012
5	Immunotherapy 11/2023 - 01/2019
3	Drug Therapy (Chemotherapy) 09/2021 - 04/2010
1	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2022
1	Stem Cell Transplantation 01/2022
1	Radiotherapy 09/2021
1	Autologous Transplantation 09/2020
1	Hematopoietic Stem Cell Transplantation 03/2016
1	Cell Transplantation 03/2016
1	Heterologous Transplantation (Xenotransplantation) 07/2015
1	Intravitreal Injections 01/2015
1	Transplantation 04/2010